Organogenesis Holdings Stock Target Price and Analyst Consensus
| ORGO Stock | USD 2.98 0.01 0.34% |
The current analyst and expert consensus on Organogenesis Holdings is Strong Buy, with 2 strong buy opinions. The current projected Organogenesis Holdings target price consensus is 3.50 with 3 analyst opinions. The most common way Organogenesis Holdings analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Organogenesis Holdings executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Organogenesis Holdings. We encourage you to use your own analysis of Organogenesis Holdings to validate this buy or sell advice. Organogenesis Holdings buy-or-sell recommendation module provides average expert sentiment on the projected Organogenesis Holdings target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Organogenesis Holdings to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
Lowest Forecast 3.19 | Highest Forecast 3.89 | Target Price 3.5 |
Organogenesis |
It's important to approach Organogenesis Holdings' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Organogenesis Holdings price targets
Organogenesis Holdings' stock target price is an estimate of its future price, usually made by analysts. Using Organogenesis Holdings' target price to determine if it is a suitable investment can be done through the following steps:- Look at Organogenesis Holdings' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Organogenesis Holdings' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Organogenesis Holdings Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Organogenesis Holdings is a key component of Organogenesis Holdings valuation and have some predictive power on the future returns of a Organogenesis Holdings.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Organogenesis Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Business Services Invested over 100 shares | |
 | Momentum Invested over 60 shares | |
Check out Macroaxis Advice on Organogenesis Holdings to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Organogenesis Stock analysis
When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
The data published in Organogenesis Holdings' official financial statements usually reflect Organogenesis Holdings' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Organogenesis Holdings. For example, before you start analyzing numbers published by Organogenesis accountants, it's critical to develop an understanding of what Organogenesis Holdings' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Organogenesis Holdings' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Organogenesis Holdings' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Organogenesis Holdings' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Organogenesis Holdings. Please utilize our Beneish M Score to check the likelihood of Organogenesis Holdings' management manipulating its earnings.